Good afternoon! The use of a buzzy class of weight loss and diabetes medications is more common than ever.from health policy research organization KFF released Friday. Roughly half of those Americans, or around 6% of U.S. adults, are currently using one of the treatments.The survey shows large numbers of Americans are taking the drugs despite intermittent shortages caused by unrelenting demand.
But the majority of all adults, regardless of whether they have taken a GLP-1, said they think Medicare should cover the cost of the drugs when prescribed for weight loss and for people who are overweight, according to the KFF survey. announced a new artificial intelligence model called AlphaFold 3, which it said can illustrate the complex interactions and structures of"all of life's molecules."AlphaFold 3 predicts the shapes and behaviors of large biomolecules such as DNA, RNA and proteins, as well as small molecules that are often used in drugs, according to a Google. When the model is prompted with a list of molecules, it can show how they all fit together by generating their joint 3D structure.
AlphaFold 3 is able to predict the interactions between proteins and other molecules at least 50% better than other existing methods, and the model doubled the prediction accuracy for other interaction categories, according to the blog post.
Technology Technology Latest News, Technology Technology Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: nbcchicago - 🏆 545. / 51 Read more »
Source: NBCDFW - 🏆 288. / 63 Read more »
Source: ForbesTech - 🏆 318. / 59 Read more »